Like many fictional characters, the mad scientist figure has its basis in real life.
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
The gene, NCF1, was known by researchers, but it had not previously been linked to lupus
OMRF has received a $200,000 grant to grow its cancer research programs.
The semiannual board meeting was held on Wednesday.
OMRF was one of 24 Oklahoma charities to receive the highest designation.